SCHEDULE 13G/A 0001137439-25-000568 0002042077 XXXXXXXX LIVE 1 American Depositary Shares 02/18/2026 0001075880 KAZIA THERAPEUTICS LTD 48669G105 THREE INTERNATIONAL TOWERS LEVEL 24, 300 BARANGAROO AVENUE SYDNEY NSW C3 2000 Rule 13d-1(c) Chernett Jorey DE 1412662.00 0.00 1412662.00 0.00 1412662.00 N 12.46 IN KAZIA THERAPEUTICS LTD Jorey Chernett (the "Reporting Person") The principal business address of the Reporting Person is 6222 Indianwood Trail, Bloomfield Hills, MI 48301. US. Y The aggregate percentage of American Depositary Shares ("ADS") owned by the Reporting Person is based upon 11,335,991 American Depository Shares outstanding as of December 11, 2025 (assuming all outstanding Ordinary Shares were represented by American Depository Shares), as disclosed in the Issuer's Prospectus filed pursuant to Rule 424(b)(3), filed with the U.S. Securities and Exchange Commission (the "SEC") on December 23, 2025. As of the close of business on February 19, 2026, the Reporting Person beneficially owned 1,412,662 ADS. 12.46% See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. See Cover Pages Items 5-9. Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Chernett Jorey /s/ Jorey Chernett 02/20/2026